DBN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.421200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.025000E-01
Normal-vs-Stage2
6.374800E-01
Normal-vs-Stage3
6.062600E-01
Normal-vs-Stage4
6.090600E-01
Stage1-vs-Stage2
5.796800E-01
Stage1-vs-Stage3
7.642200E-01
Stage1-vs-Stage4
8.232800E-01
Stage2-vs-Stage3
9.485600E-01
Stage2-vs-Stage4
9.041400E-01
Stage3-vs-Stage4
9.086200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.372600E-01
Normal-vs-AfricanAmerican
5.815000E-01
Normal-vs-Asian
6.402800E-01
Caucasian-vs-AfricanAmerican
7.260600E-01
Caucasian-vs-Asian
4.600400E-01
AfricanAmerican-vs-Asian
5.123000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.313600E-01
Normal-vs-Female
6.651600E-01
Male-vs-Female
6.374400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.235000E-01
Normal-vs-Age(41-60Yrs)
7.131000E-01
Normal-vs-Age(61-80Yrs)
6.121200E-01
Normal-vs-Age(81-100Yrs)
4.534600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.936400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.055000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.680200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.040400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.037000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.592200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.047800E-01
Normal-vs-Daily Drinker
6.041000E-01
Normal-vs-Weekly Drinker
7.897000E-01
Normal-vs-Occasional Drinker
6.577600E-01
Normal-vs-Social Drinker
6.975600E-01
Non Drinker-vs-Daily Drinker
9.865600E-01
Non Drinker-vs-Weekly Drinker
1.511200E-01
Non Drinker-vs-Occasional Drinker
6.827800E-01
Non Drinker-vs-Social Drinker
5.074800E-01
Daily Drinker-vs-Weekly Drinker
1.837790E-01
Daily Drinker-vs-Occasional Drinker
6.918000E-01
Daily Drinker-vs-Social Drinker
5.249800E-01
Weekly Drinker-vs-Occasional Drinker
3.060600E-01
Weekly Drinker-vs-Social Drinker
4.396200E-01
Occasional Drinker-vs-Social Drinker
7.865600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.780800E-01
Normal-vs-Grade 2
4.852400E-01
Normal-vs-Grade 3
5.756200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.326200E-02
Grade 1-vs-Grade 3
9.262200E-02
Grade 1-vs-Grade 4
9.780800E-01
Grade 2-vs-Grade 3
6.186200E-01
Grade 2-vs-Grade 4
4.852400E-01
Grade 3-vs-Grade 4
5.756200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.181400E-01
Normal-vs-NonDiabetic
6.771000E-01
Diabetic-vs-NonDiabetic
9.558600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.802000E-01
Normal-vs-NoPancreatitis
6.434800E-01
Pancreatitis-vs-NoPancreatitis
2.050400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.978200E-01
Normal-vs-N1
6.228800E-01
N0-vs-N1
4.398600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.613400E-01
Normal-vs-TP53-NonMutant
7.056200E-02
TP53-Mutant-vs-TP53-NonMutant
3.951500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
